Venture Life Group (VLG) Competitors

Faron Pharmaceuticals Oy (LON:FARN) and Venture Life Group (LON:VLG) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, community ranking, media sentiment, earnings, dividends and profitability.

Does the MarketBeat Community favor FARN or VLG?

Faron Pharmaceuticals Oy received 161 more outperform votes than Venture Life Group when rated by MarketBeat users. Likewise, 77.51% of users gave Faron Pharmaceuticals Oy an outperform vote while only 72.90% of users gave Venture Life Group an outperform vote.

Company	Underperform	Outperform
Faron Pharmaceuticals Oy	Outperform Votes 317 77.51%	Underperform Votes 92 22.49%
Venture Life Group	Outperform Votes 156 72.90%	Underperform Votes 58 27.10%

Which has more volatility & risk, FARN or VLG?

Faron Pharmaceuticals Oy has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Comparatively, Venture Life Group has a beta of 0.3, meaning that its stock price is 70% less volatile than the S&P 500.

Does the media refer more to FARN or VLG?

In the previous week, Venture Life Group's average media sentiment score of 0.55 beat Faron Pharmaceuticals Oy's score of 0.00 indicating that Venture Life Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Faron Pharmaceuticals Oy	Neutral
Venture Life Group	Positive

Do analysts rate FARN or VLG?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Faron Pharmaceuticals Oy	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Venture Life Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Which has higher valuation and earnings, FARN or VLG?

Venture Life Group has higher revenue and earnings than Faron Pharmaceuticals Oy. Faron Pharmaceuticals Oy is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Faron Pharmaceuticals Oy	-£725K	-317.25	-£31.61M	-£0.32	-687.03
Venture Life Group	£51.41M	1.12	£2.64M	£0.01	4,512.00

Do insiders and institutionals hold more shares of FARN or VLG?

10.7% of Faron Pharmaceuticals Oy shares are owned by institutional investors. Comparatively, 69.5% of Venture Life Group shares are owned by institutional investors. 31.8% of Faron Pharmaceuticals Oy shares are owned by company insiders. Comparatively, 10.4% of Venture Life Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Is FARN or VLG more profitable?

Venture Life Group has a net margin of 1.44% compared to Faron Pharmaceuticals Oy's net margin of 0.00%. Venture Life Group's return on equity of 1.00% beat Faron Pharmaceuticals Oy's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Faron Pharmaceuticals Oy	N/A	N/A	-70.00%
Venture Life Group	1.44%	1.00%	1.56%

Summary

Venture Life Group beats Faron Pharmaceuticals Oy on 10 of the 14 factors compared between the two stocks.